(Q72247440)
Statements
Second-line therapy with interferon-alpha plus vinblastine in metastatic renal cell cancer patients progressed under interleukin-2 subcutaneous immunotherapy (English)
F Paolorossi
S Villa
S Barni
G Tancini
M Andres